PCS
Executive Summary
As anticipated, Robert Abrams, 61, named to newly created post of VP-special projects for the prescription drug claims processing unit of McKesson. Abrams was reported to be coming to PCS in December when the company tapped California Pharmacists Association Exec VP Robert Johnson as president ("The Pink Sheet" Dec. 18, T&G-2). Johnson has now been named chairman and CEO of PCS.
You may also be interested in...
Stalemate Over Virtual Audits In EU As Commission Tells TEAM-NB To Back Off
Notified bodies’ efforts to enhance a harmonized approach to remote audits have failed, raising questions about whether there is any avenue left to get vital devices certified by the 26 May EU MDR deadline.
Amneal’s Generics Business Reinvigorated By New Launches
As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.
Medtech SMEs See Opportunities In UK Budget Of Few Surprises
Schemes and funding to support growth in the life sciences and medtech sectors featured in the UK government’s spring budget on 3 March.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: